JP2016526920A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016526920A5 JP2016526920A5 JP2016533383A JP2016533383A JP2016526920A5 JP 2016526920 A5 JP2016526920 A5 JP 2016526920A5 JP 2016533383 A JP2016533383 A JP 2016533383A JP 2016533383 A JP2016533383 A JP 2016533383A JP 2016526920 A5 JP2016526920 A5 JP 2016526920A5
- Authority
- JP
- Japan
- Prior art keywords
- replication competent
- recombinant replication
- competent retrovirus
- retrovirus
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361862433P | 2013-08-05 | 2013-08-05 | |
| US61/862,433 | 2013-08-05 | ||
| PCT/US2014/049831 WO2015021077A1 (en) | 2013-08-05 | 2014-08-05 | Recombinant vector with optimized a-bulge |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016526920A JP2016526920A (ja) | 2016-09-08 |
| JP2016526920A5 true JP2016526920A5 (enExample) | 2017-09-14 |
Family
ID=52461883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533383A Pending JP2016526920A (ja) | 2013-08-05 | 2014-08-05 | 最適化ａ−バルジを有する組換えベクター |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP3030659A4 (enExample) |
| JP (1) | JP2016526920A (enExample) |
| CN (1) | CN105579581A (enExample) |
| AU (1) | AU2014306093A1 (enExample) |
| CA (1) | CA2920049A1 (enExample) |
| WO (1) | WO2015021077A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
| EP3856910B1 (en) | 2018-09-24 | 2024-11-20 | Merck Sharp & Dohme LLC | Expression vectors for eukaryotic expression systems |
| JP7765379B2 (ja) | 2019-08-12 | 2025-11-06 | ピュリノミア バイオテック， インコーポレイテッド | Ｃｄ３９発現細胞のａｄｃｃ標的化を介してｔ細胞媒介性免疫応答を促進及び増強するための方法及び組成物 |
| EP4043012A4 (en) * | 2019-09-30 | 2024-01-24 | Shanghai Institute of Materia Medica, Chinese Academy of Sciences | Drug for treating artery-related diseases, and use thereof |
| TW202128775A (zh) | 2019-10-16 | 2021-08-01 | 英商阿法克塔生命科學有限公司 | PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分 |
| US20230304031A1 (en) * | 2020-05-11 | 2023-09-28 | Abintus Bio, Inc. | Vectors and methods for in vivo transduction |
| GB202101299D0 (en) | 2020-06-09 | 2021-03-17 | Avacta Life Sciences Ltd | Diagnostic polypetides and methods |
| TW202237657A (zh) | 2021-01-29 | 2022-10-01 | 美商默沙東藥廠 | 計畫性死亡受體1(pd-1)抗體之組合物及獲得該組合物之方法 |
| WO2022234003A1 (en) | 2021-05-07 | 2022-11-10 | Avacta Life Sciences Limited | Cd33 binding polypeptides with stefin a protein |
| TW202334196A (zh) | 2021-10-07 | 2023-09-01 | 英商阿法克塔生命科學有限公司 | Pd-l1結合多肽 |
| EP4412711A1 (en) | 2021-10-07 | 2024-08-14 | Avacta Life Sciences Limited | Serum half-life extended pd-l1 binding polypeptides |
| WO2023212483A1 (en) | 2022-04-29 | 2023-11-02 | Purinomia Biotech, Inc. | Methods and compositions for treating eosinophil driven diseases and disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4937190A (en) * | 1987-10-15 | 1990-06-26 | Wisconsin Alumni Research Foundation | Translation enhancer |
| US20050260568A1 (en) * | 2004-04-30 | 2005-11-24 | Min Gao | Hepatitis C virus assays |
| CN105624193B (zh) * | 2008-09-26 | 2021-07-13 | 索元生物医药(美国)有限公司 | 重组载体 |
| US8829173B2 (en) * | 2008-09-26 | 2014-09-09 | Tocagen Inc. | Recombinant vectors |
| US20110020814A1 (en) * | 2009-06-05 | 2011-01-27 | Ipierian, Inc. | Methods and compositions for selection of stem cells |
| CA2764107A1 (en) * | 2009-06-17 | 2010-12-23 | Tocagen Inc. | Producer cells for replication competent retroviral vectors |
-
2014
- 2014-08-05 CA CA2920049A patent/CA2920049A1/en not_active Abandoned
- 2014-08-05 AU AU2014306093A patent/AU2014306093A1/en not_active Abandoned
- 2014-08-05 WO PCT/US2014/049831 patent/WO2015021077A1/en not_active Ceased
- 2014-08-05 EP EP14835030.9A patent/EP3030659A4/en not_active Withdrawn
- 2014-08-05 CN CN201480053358.9A patent/CN105579581A/zh active Pending
- 2014-08-05 JP JP2016533383A patent/JP2016526920A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2779149T3 (es) | Vector retroviral que tiene actividad inmunoestimuladora | |
| EP2909324B1 (en) | Retroviral vector with mini-promoter cassette | |
| US11279949B2 (en) | Recombinant vectors comprising 2A peptide | |
| US11788101B2 (en) | Genomic insulator elements and uses thereof | |
| ES2911448T3 (es) | Vectores combinados y métodos para el tratamiento del cáncer | |
| JP2012503986A5 (enExample) | ||
| JP2015533510A5 (enExample) | ||
| JP2012503987A5 (enExample) | ||
| JP2024045608A (ja) | 制御性ｒｎａを発現させるためのベクターシステム | |
| JP2019503653A5 (enExample) | ||
| EP3030659A1 (en) | Recombinant vector with optimized a-bulge | |
| JP2023503858A (ja) | ４－１ｂｂｌアジュバント添加した組み換え改変ワクシニアウイルスアンカラ（ｍｖａ）の医学的使用 | |
| Everson et al. | Retroviral vector interactions with hematopoietic cells | |
| TWI817997B (zh) | 結合至階段特異性胚胎抗原4 (ssea4)之嵌合抗原受體及其用途 | |
| EP4249596A1 (en) | New gene recombinant vaccinia virus and utilization thereof | |
| Weber et al. | Retroviral vectors | |
| Abaan et al. | Gene therapy in human breast cancer | |
| US11970708B2 (en) | Gene therapy vector with minimizing recombination, recombinant retrovirus comprising the vector, and pharmaceutical composition for preventing or treating cancer comprising the recombinant retrovirus | |
| RU2697797C2 (ru) | Генетическая конструкция для индукции пролиферации периферических моноцитов in vitro | |
| JP2024526878A5 (enExample) | ||
| JP2024526878A (ja) | 調節されたウイルス送達システムおよびその使用 | |
| CN1162643A (zh) | 用于癌症治疗的分子嵌合体的制备方法及应用 | |
| HK40034205A (en) | Chimeric antigen receptors that bind to ssea4 and uses thereof | |
| WO2018073307A1 (en) | Mlv-based gene therapy with mutated integrase coupled to peptides |